Published in Aust Vet J on August 01, 2010
Non-invasive assessment of equine muscular function: A case study. Open Vet J (2013) 0.76
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ (2000) 5.64
Clinical effects and treatment of imipramine and amitriptyline poisoning in children. Br Med J (1967) 3.47
Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol (1982) 3.12
Self-disclosure of HIV infection to sexual partners. Am J Public Health (1991) 2.86
Culturally sanctioned secrets? Latino men's nondisclosure of HIV infection to family, friends, and lovers. Health Psychol (1995) 2.71
Women's self-disclosure of HIV infection: rates, reasons, and reactions. J Consult Clin Psychol (1995) 2.58
Health behavior of elderly Hispanic women: does cultural assimilation make a difference? Am J Public Health (1987) 2.23
In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature (1993) 2.19
The association between acculturation and health practices among middle-aged and elderly Latinas. Ethn Dis (1999) 2.13
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Women need to be warned about dangers of hormone replacement therapy. BMJ (1997) 2.02
Allele loss on short arm of chromosome 17 in breast cancers. Lancet (1988) 1.86
Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77
ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics. BMJ (1994) 1.77
Cultural diversity in the predictors of adolescent cigarette smoking: the relative influence of peers. J Behav Med (1994) 1.76
p53 mutations in breast cancer. Cancer Res (1992) 1.73
Self-disclosure of HIV infection: preliminary results from a sample of Hispanic men. Health Psychol (1992) 1.71
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
The use of videotaped information in cancer genetic counselling: a randomized evaluation study. Br J Cancer (1998) 1.61
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer (1998) 1.60
Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet (1991) 1.58
Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci U S A (1994) 1.55
High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene (1989) 1.52
Parenting style and adolescent depressive symptoms, smoking, and academic achievement: ethnic, gender, and SES differences. J Behav Med (1996) 1.50
Physiological variation in circulating B cell:T cell ratio in man. Nature (1974) 1.50
MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene (1991) 1.49
The sheep-cell rosette: test on human peripheral blood lymyphocytes: an analysis of some analysis of some variable factors in the technique. Br J Haematol (1974) 1.49
Human MHC class II molecules as differentiation markers. Immunogenetics (1982) 1.45
Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer (1987) 1.45
RFLP for the human erbA2 gene. Nucleic Acids Res (1986) 1.45
Improving the predictability of performance by prerace detection of dorsal metacarpal disease in thoroughbred racehorses. Aust Vet J (2000) 1.39
T-shaped malformation of the ventral colon in a Thoroughbred filly with colic. Aust Vet J (2010) 1.38
Age-related variation in proportion of circulating T cells. Lancet (1974) 1.33
HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort. Br Med J (Clin Res Ed) (1988) 1.27
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer (1990) 1.24
The CAG repeat within the androgen receptor gene in male breast cancer patients. J Med Genet (2000) 1.22
HL-A typing of cultured peripheral lymphoblastoid cells. Tissue Antigens (1972) 1.21
HIV-infected men's practices in notifying past sexual partners of infection risk. Public Health Rep (1992) 1.21
Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta (2008) 1.21
Anal intercourse and disclosure of HIV infection among seropositive gay and bisexual men. J Acquir Immune Defic Syndr (1994) 1.21
Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene (1990) 1.19
Human lymphoblastoid cell lines. 3. Co-cultivation technique for establishment of new lines. J Natl Cancer Inst (1972) 1.19
Vertical transmission of HIV: a prospective study. Arch Dis Child (1989) 1.18
Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5. Am J Hum Genet (1990) 1.17
Genetic studies on human lymphoblastoid lines: isozyme analysis on cell lines from forty-one different individuals and on mutants produced following exposure to a chemical mutagen. Ann Hum Genet (1973) 1.17
Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer (1991) 1.17
Evidence of altered antigenicity in cultured lymphoid cells from patients with infectious mononucleosis. Lancet (1970) 1.16
A public health framework for addressing black and white disparities in preterm delivery. J Am Med Womens Assoc (2001) 1.16
Language acculturation and screening practices of elderly Hispanic women. The role of exposure to health-related information from the media. J Aging Health (1992) 1.16
Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol (1987) 1.16
Landmark identification error in posterior anterior cephalometrics. Angle Orthod (1994) 1.15
Studies on adrenaline-induced leucocytosis in normal man. I. The role of the spleen and of the thoracic duct. Br J Haematol (1971) 1.15
p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer (1992) 1.14
Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg (1994) 1.14
Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature (1978) 1.12
Studies on adrenaline-induced leucocytosis in normal man. II. The effects of and adrenergic blocking agents. Br J Haematol (1971) 1.11
p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status. Br J Cancer (1994) 1.11
Risk factors for breast cancer. BMJ (1995) 1.07
The interaction of normal lymphocytes nd cells from lymphoid cell lines. 3. Studies on activation in an autochthonous system. Immunology (1973) 1.07
Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer (1992) 1.06
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer. Dis Markers (1999) 1.05
Human lymphoblastoid cell lines. I. Culture methods and examination for Epstein-Barr virus. J Natl Cancer Inst (1971) 1.05
Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer (1993) 1.04
Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br J Cancer (1991) 1.04
Linkage of a major breast cancer gene to chromosome 17q12-21: results from 15 Edinburgh families. Am J Hum Genet (1993) 1.04
Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate. Eur J Immunol (1983) 1.03
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer (1992) 1.03
T-cell proliferation and expression of MHC class II antigens. Scand J Immunol (1984) 1.00
Non-random chromosome gains in human lymphoblastoid cell lines. Nature (1977) 1.00
A mild procedure for separating polypeptide chains prior to immunoprecipitation and western blotting analysis. J Immunol Methods (1984) 1.00
Prospective psychosocial, interpersonal, and behavioral predictors of handgun carrying among adolescents. Am J Public Health (1998) 0.99
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res (1996) 0.99
Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br J Cancer (2001) 0.99
Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. BMJ (1990) 0.99
DNA in medicine. The tools. Part I. Lancet (1984) 0.99
HTLV-III infection associated with glandular-fever-like illness in a haemophiliac. Lancet (1985) 0.98
Characteristics of eighth-grade students who initiate self-care in elementary and junior high school. Pediatrics (1990) 0.98
The interaction of normal lymphocytes and cells from lymphoid cell lines. IV. HL-A typing of the cell line cells. Immunology (1973) 0.97
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer (1988) 0.97
A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg Br (1992) 0.96
High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci. Br J Cancer (1996) 0.96
Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines. Int J Cancer (1992) 0.96
The G2 chromosomal radiosensitivity assay. Int J Radiat Biol (2002) 0.95
DNA in medicine. The tools. Part II. Lancet (1984) 0.94
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers (1999) 0.94
Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control (1995) 0.93
Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int J Cancer (1994) 0.93
Multimeasure pain assessment in an ethnically diverse group of patients with cancer. J Transcult Nurs (1999) 0.93
Path model of multidimensional compliance with cancer therapy. Health Psychol (1987) 0.93
Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. Br J Cancer (1993) 0.92
Linkage analysis in familial adenomatous polyposis: order of C11P11 (D5S71) and pi 227 (D5S37) loci at the apc gene. Genomics (1989) 0.92
Production and regulation of interleukin 6 in human B lymphoid cells. Eur J Immunol (1990) 0.92
A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer (1999) 0.92
Cytotoxic potential of lymphocytes stimulated with autochthonous lymphoid cell line cells. Experientia (1971) 0.91
Endocrine studies in a case of congenital (erythroid) hypoplastic anaemia. Acta Haematol (1972) 0.91
Role of health locus of control beliefs and expectations of treatment efficacy in adjustment to cancer. J Pers Soc Psychol (1986) 0.90
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res (2002) 0.90
Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic. Br J Cancer (2001) 0.89
Role of health locus of control beliefs in cancer screening of elderly Hispanic women. Health Psychol (1993) 0.89